Health Daily American Samoa: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Daily American Samoa.

Press releases published on September 17, 2026

3 hours ago

NeOnc Eliminates Major Dilution Risk as Clinical Story Accelerates

Indeterminate GlobeNewswire

3 hours ago

BayCare Names Brendan Malik, MD, Vice President of Physician Enterprise Development and Chief Medical Officer

Indeterminate GlobeNewswire

3 hours ago

Ernexa Therapeutics Appoints Accomplished Biopharmaceutical Executive Robert J. Spiegel, M.D., FACP, to Board of Directors

Indeterminate GlobeNewswire

3 hours ago

Sienna Continues Platform Growth in Ontario

Indeterminate GlobeNewswire

3 hours ago

MIRA Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Following FDA Review

Indeterminate GlobeNewswire

3 hours ago

Telomir Announces Peer-Reviewed Publication Showing Telomir-Zn Restores Visual Function and Retinal Structure in a Model of Age-Related Macular Degeneration (AMD)

Indeterminate GlobeNewswire

3 hours ago

Emanate Receives FDA 510(k) Clearance for Perio PODS™, the First FDA-Cleared At-Home Periodontal Wound Dressing Indicated Following Non-Surgical Periodontal Procedures

Indeterminate GlobeNewswire

3 hours ago

PetMeds Appoints Jeff Willard as CEO & President and Announces Board Leadership Transition

Indeterminate GlobeNewswire

3 hours ago

Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress

Indeterminate GlobeNewswire

3 hours ago

TOMI’s SteraMist Integrated System (SIS) Strategy Converts to Orders: Enclosure Sales Reach $2.3 Million YTD

Indeterminate GlobeNewswire

3 hours ago

PharmAla Biotech Provides Corporate Update: Change of Auditor, Retention of Watertower Research and Oak Hill

Indeterminate GlobeNewswire

3 hours ago

Sol-Gel Technologies Announces Last Patient Last Visit in Pivotal Phase 3 Clinical Trial of SGT-610 in Gorlin Syndrome

Indeterminate GlobeNewswire

3 hours ago

Commure Named to TIME's World’s Top HealthTech Companies for Second Consecutive Year

Indeterminate GlobeNewswire

3 hours ago

Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging Pharma

Indeterminate GlobeNewswire

4 hours ago

Matisse Pharmaceuticals closed Series A financing round to advance isupartob sodium through phase 2 clinical development

Indeterminate GlobeNewswire

4 hours ago

Aerska Appoints Laura Sepp-Lorenzino to Scientific Advisory Board

Indeterminate GlobeNewswire

4 hours ago

Recludix Pharma to Present at the Stifel 2026 Virtual Immunology and Inflammation Forum

Indeterminate GlobeNewswire

4 hours ago

Hemab Therapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of HMB-003, an Investigational Therapy for the Management of Heavy Menstrual Bleeding

Indeterminate GlobeNewswire

4 hours ago

Quince Therapeutics to Host Virtual KOL Event to Discuss the Current Treatment Landscape for PH-ILD and BOS and the Role for LAM-001 as a Potential Therapeutic Option on September 28, 2026

Indeterminate GlobeNewswire

4 hours ago

Regenerative Farming Outpaces Tech-Based Carbon Capture Solutions in First Large-Scale Systemic Study

Indeterminate GlobeNewswire